跳至主要内容
临床试验/TCTR20230516010
TCTR20230516010已完成2 期

A Comparative Study of the Efficacy and Safety of Leard-ngam Remedy Versus Mefenamic Acid in Relieving Primary Dysmenorrhea

Chulabhorn International College of Medicine, Thammasat University0 个研究点目标入组 72 人开始时间: 2023年5月16日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
72

研究概览

简要总结

eard-ngam remedy could relieves primary dysmenorrhea when compared with Mefenamic acid. Leard-ngam remedy safe in relieving primary dysmenorrhea.

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 25 Years(—)
性别
Female

入选标准

  • 1 Female aged 18-25 years
  • 2 BMI 18.5-22.90
  • 3 Being Single
  • 4 Suffers from primary dysmenorrhea (VMS grade 1-2, VAS level 1-7) and diagnosed by the gynecologist
  • 5 Having regular menstrual cycle
  • 6 Requires analgesic drug for relieving pain

排除标准

  • 1 Pregnant or breastfeeding
  • 2 Taking oral contraceptive medicine
  • 3 Secondary menstrual cramps assessed by an obstetrician
  • 4 Having severe gastrointestinal, gynecological, or autoimmune diseases
  • 5 Receiving gynecological surgery within 1 year prior to the physical examination
  • 6 Having medicinal and herbal sensitivities
  • 7 Taking any other drugs apart from analgesic.
  • 8. Taking dietary supplements such as evening primrose.
  • 9. Having Blood diseases with disorders of the blood coagulation system and volunteers taking blood clot-dissolving drugs
  • 10. Abnormalities are detected through physical examination, vital signs, heart rate, blood pressure.
  • 11. Abnormal laboratory include biochemistry (electrolytes, liver function, kidney function, serum protein, lipid profile, uric acid), hematology (RBC, WBC, platelet counts), and urinalysis.
  • 12. In the process of another research project

研究者

发起方
Chulabhorn International College of Medicine, Thammasat University

相似试验